Introducing our significantly expanded contract services at "INTERPHEX JAPAN 2023"! We will also hold seminars within our booth!
【Exhibition Information】 We will be exhibiting at the 23rd Interphex Japan! Sperapharma will be exhibiting at the 23rd Interphex Japan (December 8-10, 2021, Makuhari Messe). Since becoming Astena HD in June of this year, we have significantly expanded the contract services we can offer, and we would like to introduce them to you. We are also planning seminars within our booth, so please be sure to check those out as well! For seminar information, please refer to the related links. All of our staff sincerely look forward to welcoming you.
Inquire About This Product
basic information
**23rd INTERPHEX JAPAN** Date: December 8 (Wednesday) - 10 (Friday), 2021 Venue: Makuhari Messe, Hall 9, 2-2 *Advance registration (INTERPHEX JAPAN e-invitation ticket) is required for attendance.* ★Exhibitor Presentation Date and Time: December 8 (Wednesday) 15:30-16:00 Venue: Presentation Stage B Title: Expansion of Contract Services at Spira Pharma - From CMC Drug Development to Commercial Production - Abstract: The scope of contract services has expanded from the CMC drug development stage to commercial manufacturing. We will introduce an overview of this expansion and also present injection facilities that can respond globally. Speaker: Yukihiro Nomura, Group Manager, Sales Department, Fine Chemical Sales Division, Spira Pharma Co., Ltd.
Price range
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is a pharmaceutical CMC research and development contract company that spun out from the CMC research division of Takeda Pharmaceutical Company Limited in July 2017. We support excellent pharmaceutical development as experts in CMC research. Our research team consists of experts with extensive experience and achievements in process chemistry, formulation research and development, and analytical testing development related to CMC research. We provide high-level services and solutions tailored to our customers' needs across each process from the early stages of pharmaceutical development to application, while flexibly collaborating. We have established a collaborative system with partner companies, enabling us to offer a one-stop service. Please utilize us as a platform for your pharmaceutical development.